[1]. Ren A et al., Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer. Int J Cancer. 2019 Jul 1;145(1):154-163. PMID: 30561001
[2]. Shen Y, Zhang W, Liu J, He J, Cao R, Chen X, Peng X, Xu H, Zhao Q, Zhong J, Ding W, Lei X, Jiang Y, Zu X. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET. Int J Cancer. 2019 Feb 1;144(3):651-664. doi: 10.1002/ijc.31915. Epub 2018 Nov 7.PMID: 30289981
[3]. Xu H, Han H, Song S, Yi N, Qian C, Qiu Y, Zhou W, Hong Y, Zhuang W, Li Z8, Li B, Zhuang W. Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma. Clin Cancer Res. 2019 Jan 4. pii: clincanres.2363.2018. doi: 10.1158/1078-0432.CCR-18-2363. PMID: 30610101
[4]. Li B, Han H, Song S, Fan G, Xu H, Zhou W, Qiu Y, Qian C, Wang Y, Yuan Z, Gao Y, Zhang Y, Zhuang W. HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with its Natural Antisense Transcript lncHOXC-AS3. Stem Cells. 2018 Oct 23. doi: 10.1002/stem.2925. PMID: 30353595
[5]. Shi J, Song S, Han H, Xu H, Huang M, Qian C, Zhang X, Ouyang L, Hong Y, Zhuang W, Li B. Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma. Mol Pharm. 2018 Sep 4;15(9):4139-4147. doi: 10.1021/acs.molpharmaceut.8b00554. Epub 2018 Aug 9. PMID: 30048594
[6]. Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, Qian C, Hong Y, Qiu Y, Zhou W, Huang M, Zhuang W. Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018 Oct;37(41):5508-5519. doi: 10.1038/s41388-018-0359-0. Epub 2018 Jun 12. PMID: 29895968
[7]. Yuan Y, Qi G, Shen H, Guo A, Cao F, Zhu Y, Xiao C, Chang W, Zheng S. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31736. PMID: 29987896
[8]. Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018 Jun;68(6):1214-1227. PMID: 29378234
[9]. Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, Sun M, Chen B, Zhao W, Wang L, Wang H, Moran MS, Haffty BG, Yang Q.SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Cell Death Differ. 2018 Jul 9. doi: 10.1038/s41418-018-0158-8. PMID: 29988076
[10]. Du L, Han XG, Tu B, Wang MQ, Qiao H, Zhang SH, Fan QM, Tang TT. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis. Cell Death Dis. 2018 Jun 18;9(7):714. PMID: 29915309
[11]. Zhou P, Qin J, Li Y, Li G, Wang Y, Zhang N, Chen P, Li C. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. J Exp Clin Cancer Res. 2017 Sep 2;36(1):115. PMID:28865485
[12]. Wang X, Cheng Y, Zhu Y, Li H, Ge W, Wu X, Zhao K, Yuan J, Li Z, Jiang S, Han Z, Jiang Q, Wu Q, Liu T, Zhang C, Yu M, Hu Y. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30852. PMID: 28656647
[13]. Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, Guo F, He Y, Liu Y, Huang Q, Liang H, Li D, He F. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017 Aug 24;8(1):347. doi: 10.1038/s41467-017-00299-9. PMID: 28839186
[14]. Wang C, Li L, Yin Z, Zhang Q, Zhao H, Tao R, Wang S, Hu S, He Y, Wang D, Li C, Zhang S, Xu J, Jiang X, Zhu S, Gao Y. An Indel Polymorphism within pre-miR3131 Confers Risk for Hepatocellular Carcinoma. Carcinogenesis. 2017;38:168-76. PMID:28034876
[15]. Wang X, Yu M, Zhao K, He M, Ge W, Sun Y, Wang Y, Sun H, Hu Y. Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2. Cell Death Dis. 2016;7(12):e2517. PMID:27929537
[16]. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, Wang J, Wang R, She J, Zhang J, Yang J, Liu Y, Liu P. CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin. Oncogenesis. 2017 Apr 24;6(4):e322. PMID:28436991
[17]. Du J, Shang J, Chen F, Zhang Y, Yin N, Xie T, Zhang H, Yu J, Liu F. A CRISPR/Cas9-Based Screening for Non-Homologous End Joining Inhibitors Reveals Ouabain and Penfluridol as Radiosensitizers. Mol Cancer Ther. 2018 Feb;17(2):419-431. PMID: 28864683
[18]. Chen L, Aleshin AE, Alitongbieke G, Zhou Y, Zhang X, Ye X, Hu M, Ren G, Chen Z, Ma Y, Zhang D, Liu S, Gao W, Cai L, Wu L, Zeng Z, Jiang F, Liu J, Zhou H, Cadwell G, Liddington RC, Su Y, Zhang XK. Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.Nat Commun. 2017 Jul 17;8:16066. PMID:28714476
[19]. Li H, Wang X, Zhang C, Cheng Y, Yu M, Zhao K, Ge W, Cai A, Zhang Y, Han F, Hu Y. HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma. Cancer Lett. 2018 Sep 28;432:121-131. PMID: 29890207
[20]. Lu-Hua Zhang, Yi-Heng Yin, Hong-Zun Chen, Shi-Yu Feng, Jia-Lin Liu, Ling Chen, Wen-Liang Fu, Guo-Chen Sun, Xin-Guang Yu, Dong-Gang Xu. TRIM24 Promotes Stemness and Invasiveness of Glioblastoma Cells via Activating SOX2 Expression. Neuro Oncol. 2020 Jun 3;noaa138. doi: 10.1093/neuonc/noaa138.
[21]. Ke Nie, Jin Li, Xujun He, Yuqing Wang, Qiongya Zhao, Miaomiao Du, Hongwei Sun, Jinjing Wang, Jianxin Lyu, Hezhi Fang, Liqin Jin. COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells. Oncogenesis. 2020 May 15;9(5):51. doi: 10.1038/s41389-020-0231-2.
[22]. Si-Jing Li, Xiao-Hui Wei, Xiao-Man Zhan, Jin-Yong He, Yu-Qi Zeng, Xue-Mei Tian, Sheng-Tao Yuan, Li Sun.Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner. Cancers (Basel). 2020;12(12):3864. doi: 10.3390/cancers12123864. PMID: 33371368
[23]. Xiaolong Zhang, Qinli Ruan, Yiqian Zhai, Dandan Lu, Chen Li, Yahan Fu, Zihui Zheng, Ying Song, Jun Guo.Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment. Cancer Sci. 2020;111(10):3802-3812. doi: 10.1111/cas.14577.PMID: 32691974
[24]. Xiaoying Hou, Hongzhi Du, Xingping Quan, Lei Shi, Qianqian Zhang, Yao Wu, Yang Liu, Jing Xiao, Yong Li, Ligong Lu, Xun Ai, Meixiao Zhan, Shengtao Yuan, Li Sun. Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway. Front Pharmacol. 2018;9:21. doi: 10.3389/fphar.2018.00021. PMID: 29472856
[25]. Biao Geng, Jinshun Pan, Ting Zhao, Jie Ji, Chen Zhang, Ying Che, Jing Yang, Hui Shi, Juan Li, Hong Zhou, Xianmin Mu, Che Xu, Chao Wang, Yue Xu, Zheng Liu, Hao Wen, Qiang You.Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37(1):208. doi: 10.1186/s13046-018-0876-2.PMID: 30165890